Multiple Myeloma: International Myeloma Foundation : publications : meeting highlights : Phase I/II Study of a Combination of Velcade, Melphalan, Prednisone, and Thalidomide (VMPT) for Relapsed Myeloma

We are international

the basics

myeloma today

myeloma minute

meeting highlights

back

Phase I/II Study of a Combination of Velcade, Melphalan, Prednisone, and Thalidomide (VMPT) for Relapsed Myeloma

	12.17.06
Phase I/II Study of a Combination of Velcade, Melphalan, Prednisone, and Thalidomide (VMPT) for Relapsed Myeloma Be the first to comment	print share \| related articles